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The mducible NO synthase (iNOS) was found to be expressed in pancreatic lesions of adult diabetes-prone BB rats Pancreatic iNOS mRNA was 
detected by reverse transcriptase PCR in pancreatic RNA of adult diabetes-prone BB rats but not in normal Wistar rats, young diabetes-prone 
BB rats without msulitis or m diabetes-reststant BB rats. Immunohistochemistry of pancreattc sections using an iNOS-specific antiserum labeled 
the pancreas of adult diabetes-prone BB rats but not Wistar rats. Parallel staining for EDl-posittve macrophages showed restriction of iNOS 
expression to areas of islet infiltration by macrophages. In conclusion. the data provide direct evidence for enhanced expression of inducible NO 
synthase in tissue lesions durmg the development of autoimmune diabetes. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Nitric oxide (NO) has been identified in experimental 
models in vitro as a highly toxic compound for pancre- 
atic islet cells. The lysis of islet cells by activated macro- 
phages in culture is dependent on NO generated by the 
inducible NO synthase (iNOS) of macrophages [l]. The 
lytic activity of IL-1 towards isolated islets also requires 
iNOS activity [2]. Under non-lytic conditions IL-l mod- 
ulates insulin secretion after glucose stimulus via the 
induction of NO formation [3,4]. Finally, chemically 
generated NO was found to rapidly lyse islet cells, but 
was of lesser toxicity towards other cell types [5]. 
Although these and other findings have led to the 
suggestion that NO is a pathogenic factor in inflamma- 
tory or autoimmune diseases, direct evidence for en- 
hanced iNOS expression at the site of local lesions is 
lacking for spontaneous inflammatory/autoimmune 
disease. We therefore studied diabetes-prone BB rats, 
which represent a spontaneous model of human type I 
diabetes. The disease in BB rats is macrophage- and 
T-cell-dependent. Insulin-dependent diabetes results 
from preferential p cell destruction during chronic pro- 
gressive insulitis [6]. We demonstrate here the presence 
of iNOS in pancreatic lesions of prediabetic BB rats. 
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2.1. Animals 
Diabetes-prone and diabetes-resistant BB rats were obtained from 
Mollegaard Ltd., Eiby, Denmark (BBIWorlMol) and from the Uni- 
versity of Massachusetts at Worcester, USA (BB/Wor/dp and BBI 
Wor/dr) at 4-5 weeks of age and maintained in our animal facility 
under standard conditions. Animals received tap water and rat chow 
(ssniff R. Ssniff, Soest, Germany) ad hbitum. Breeding stocks of Wis- 
tar rats came from the Zentralinstitut fur Versuchtierkunde. Han- 
nover, Germany Diabetes-prone BB rats of both sexes were killed 
under anesthesia for pancreatic analysis at 5 weeks of age or between 
9 and 11 weeks of age (when about 20% of httermates had developed 
diabetes). Diabetes-resistant BB rats and Wistar rats were killed be- 
tween 9 and 12 weeks of age. 
2.2. mRNA analysis 
Vascular endothelial cells were isolated by outgrowth for 66 days 
from aortic rings on collagen gel following standard procedures [7]. 
Cells were subcultured for 3-6 passages, lo6 cells were cultured on 
coverslips with or without 200 U/ml of human recombinant inter- 
leukin lb (Genzyme, Cambridge, MA, USA) plus 100 U/ml rat inter- 
feron y (HBT. Leiden, Netherlands) for 6 h. RNA was isolated from 
endothehal cells or from fresh pancreatic tissue by acid guanidimum 
thiocyanate-phenol+zhloroform extraction [8]. Northern blotting of 
10 pg RNA per lane was performed following standard procedures [9] 
usmg a cDNA of RAW 264.7 macrophage line iNOS [lo] or a cDNA 
of endothelial cNOS [ll] (kind gift of Dr. K.D. Bloch, Massachusetts 
General Hospital, Boston, USA). Of the iNOS cDNA the MboI- 
BanrHI fragment, bases 494845. was used as probe, of the cNOS 
cDNA bases I-606. Reverse transcrtptase PCR was applied to detect 
iNOS mRNA in pancreatic RNA. Bases 200-866 were converted into 
cDNA using a specific primer, followed by polymerase chain reaction 
with 6 pg pancreatic RNA [12]. After a total of 35 cycles the product 
was subjected to electrophoresis on a 2% agarose gel followed by 
hybridization with iNOS and cNOS probes as described above. 
Abbrevzations~ iNOS, inducible NO synthase; cNOS, constitutive 2.3. Immunohistochemutry and Western blot analysis 
NOS. Serial cryostat sections (5 pm) of pancreata were prepared, dried 
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and fixed wth acetone at room temperature for IO mm Indlrect 
lmmunohlstochemlstry was performed as described prewously [I31 
The followmg antlbodies were used: monoclonal mouse antibody ED1 
(Serotec. Oxford. LIK). rabbit hqperlmmune serum to mouse macro- 
phage iNOS [IO]. and peroxldase-based detection kits (Vectastam. 
Vector. Burlmgame. USA) Slides were evaluated by two Independent 
obsercers 
Cultures of endothehal cells (\ee sectlon 3.2) were dried and subse- 
quently processed as described above For Western blot analysts ap- 
prox IO” endothehal cells were lysed by 3% SDS buffer followed by 
electrophoresls on a 10% polyacrylamlde gel. blotting and Immunocy- 
tocheml\try using standard protocols [I41 
3. RESULTS 
The cDNA probes of iNOS and cNOS were chosen 
from the N-terminal region since it contains the largest 
sequence differences between the two enzymes. As 
shown in Fig. IA the iNOS and cNOS specifically detect 
inducible versus constitutive NOS message in endothe- 
lial cells. Using amplification by reverse transcriptase 
PCR the iNOS message was not detectable in non-actl- 
vated endothelial cells. nor in pancreas of normal Wis- 
tar or diabetes resistant BB rats (Fig. 1 B). In contrast. 
strong signals of iNOS mRNA were found in pancreata 
of diabetes-prone BB rats at 9-11 weeks of age. an age 
where all diabetes-prone BB rats exhibited insulitis (see 
immunohistochemistry below). Diabetes-prone BB rats 
did not express iNOS mRNA in the pancreas prior to 
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Fig. I. (A) Demonstration of iNOS and cNOS mRNA m endothehal 
cells by Northern blot Lane I+?. hybrldlratlon wth cNOS probe: 
lane 3+3. INOS probe. lane 5+6./Gactm probe. (B) Analysis for iNOS 
mRNA in pancreatic RNA by reverse transcrtptase PCR. Lanes l-6. 
hqbrldlratlon of PCR products with iNOS probe: lanes 7-13, cNOS 
probe. E-. non-activated endothehum: E+. activated endothehum, 
Bl. 5-week-old BB rat pancreas. 83. adult diabetes-prone BB rat 
pancreas: B dr. diabetes-resistant BB rat pancreas: WI, Wlstar rat 
pancreas In each case RNA of 3 different pancreata was analqsed 
mlth Identical results. 
the onset of insulitis. at an age of 5 weeks (Fig. 1 B). The 
absence of insulitis was verified by histological analysis. 
Translation of iNOS transcripts m adult diabetes- 
prone BB rats was analysed by an iNOS-specific antise- 
rum. Control experiments with resident and activated 
endothelials confirmed specificity of the antibody (Fig. 
2). Staining for iNOS was found in pancreatic sections 
of adult diabetes-prone BB but not in control Wistar 
rats. In order to localize iNOS expression two serial 
pancreas sections were stained in parallel for macro- 
phage infiltration (ED1 marker) and iNOS expression. 
c 
1 2 
Fig. 2 Evaluation of rabbit anti-INOS antlserum. (A) Immunocytochemlstry with non-stlmulatcd endothehal cells The cytoplasm around the 
recogmzeable nuclei IS not stained. (B) ImmunoqtochemIstry with cytoklne activated cndothehal cells. Seen is an mten5e stalnmg of the cytoplasm 
(C)Western blot analysis wth lysate of (I 1 activated or (3) normal endothelial cell!, The molecular weight markers of32 and 100 kDa are Indicated 
The antlserum reacts wth a protem of 130~~130 hDa MU’ III lane I. 
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Table I 
Assoctatton of 1NOS positivtty wtth macrophage infiltration of Islets 
No. of islets 
Wtthout mfiltratlon 
-- 
Total iNOS pos. 
(EDl+-cells 6 4) 
_-.-- 
ED1 pos. 
With Infiltration 
iNOS nos. ED1 pos. 
iNOS pos 
Adult BB rats, 
diabetes-prone 
(n = 4) 
Wistar rats (n = 3) 
76 0 47 46 46 
19 0 1 0 0 
Staining with iNOS antibodies was found in areas of 
macrophage infiltration of islets from diabetes-prone 
BB rats (Fig. 3). Semiquantitative analysis showed mac- 
rophage infiltration in 47 of 73 islets in adult diabetes- 
prone BB rats versus 1 of 30 islets in age-matched Wis- 
tar rats (Table I). Nearly all islet areas with macrophage 
infiltration also stained for iNOS while in no case iNOS 
protein was demonstrated in islets in the absence of 
EDl’ cells (Table I). 
4. DISCUSSION 
The data presented demonstrate the presence of 
iNOS gene transcripts and of iNOS protein in pancre- 
atic lesions of adult diabetes-prone BB rats. The expres- 
sion of the iNOS gene is disease-associated, iNOS 
mRNA was not detected in pancreata of normal Wistar 
rats. of young diabetes-prone BB rats prior to the onset 
of recognizable insulitis and of diabetes-resistant BB 
rats. Recently, a first study of iNOS mRNA expression 
in experimentally induced autoimmunity showed gene 
expression in the brain of rats after immunization with 
myelin basic protein [15]. Thus, expression of iNOS in 
target organs occurs in both, spontaneous and experi- 
mental autoimmunity. In the present study, we made 
use of a specific antiserum to identify the site of iNOS 
expression. 
Immunohistochemistry showed a clear association of 
iNOS with islet areas of macrophage infiltration. In no 
case iNOS was found in the absence of EDl-positive 
cells. This indicates that macrophages themselves ex- 
press iN0.S. In addition, macrophages may have in- 
duced adjacent endothelial or endocrine islet cells by 
inflammatory mediators to secrete NO. Such mediators 
are IL-l and TNFa, expression of these genes has been 
shown in inflamed islets of BB rats [16]. It has also been 
shown that highly purified p islet cells are able to pro- 
duce NO upon challenge with cytokines [17]. Whether 
iNOS expression by endocrine cells occurs in vivo is not 
known. The present data indicate that the possible con- 
tribution of B cell iNOS is restricted to the close vicinity 
of macrophages. The other possible site of iNOS expres- 
sion is the islet endothelium. In fact. recent studies have 
shown that islet endothelial cell cultures respond to cy- 
tokine challenge with sustained NO release [18]. 
In any case there is a striking association of iNOS 
expression with a local infiltrate of ED1 positive macro- 
phages, which indicates a contribution of inflammatory 
macrophages to iNOS induction and expression. In this 
context it is of interest that macrophages from various 
organs of diabetes-prone BB rats respond to proper 
stimuli with excessive release of TNFa and oxygen rad- 
icals [19,30]. This inflammatory hyperreactivity of BB 
rat macrophages may promote iNOS expression at sites 
of macrophage infiltration. 
Fig. 3. Immunocytochemtstry of pancreatic secttons. (A) Section of a 
IO-week-old iabetes-prone B3 rat stained for EDl. (B) The adjacent 
sectmn stamed for iNOS. Both antigens show the same pattern of 
distrlbutlon Islet areas negatrve for INOS do not show EDI staining 
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In summary, we show here for the first time the en- 
hanced transcription and translation of iNOS in areas 
of inflammation during spontaneous autoimmunity. 
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